Goldman Sachs Says China Biotech Is Where Big Pharma Is Shopping Now
Goldman Sachs analyst Salveen Richter says big pharma is shopping in China biotech as $440 billion in drugs lose patents. The post Goldman Sachs Says China Biotech Is Where Big Pharma Is Shopping Now appeared first on BeInCrypto.
Key Takeaways
- Goldman Sachs analyst Salveen Richter says big pharma is shopping in China biotech as $440 billion in drugs lose patents.
- The post Goldman Sachs Says China Biotech Is Where Big Pharma Is Shopping Now appeared first on BeInCrypto.
- Read the full article for additional context and details.
Summary generated by IndiCrypto from BeInCrypto. IndiCrypto is a news aggregator and does not provide investment advice. Read the original article for full context.
More in Web3
S&P 500 Breaks Records But Analysts Split on Whether Rally Can Broaden
The S&P 500 record high above 7,800 splits money managers on whether the rally can broaden beyond big tech and Fed hikes. The post S&P 500 Breaks Records But Analysts Split on Whether Rally Can Broaden appeared first on BeInCrypto.
XRP Could Skip Final Rally and Fall Toward $1.27 Support
XRP’s tightening range is nearing a decision point below $1.65, with one analyst saying the crypto token does not need another high before a larger pullback begins. The setup still leaves room for a stronger breakout if buyers reclaim nearby resistance. XRP…
Abstract's Shutdown Lifts the Pudgy Penguins NFT Floor but Weighs on Its Token
Abstract, a blockchain built for consumer crypto apps, is shutting down after almost three years. It joins hundreds of crypto projects that have already closed in 2026. The news has turned attention back to Pudgy Penguins. The non-fungible token (NFT) floor…